Private Capital Management (Florida)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.79M Sell
135,000
-200,000
-60% -$5.32M 0.38% 45
2025
Q4
$8.34M Buy
335,000
+95,000
+40% +$2.4M 0.76% 30
2025
Q3
$6.12M Sell
240,000
-20,000
-8% -$494K 0.55% 37
2025
Q2
$6.3M Buy
260,000
+135,000
+108% +$3.15M 0.61% 34
2025
Q1
$3.17M Buy
125,000
+30,000
+32% +$785K 0.35% 41
2024
Q4
$2.52M Buy
+95,000
New +$2.58M 0.26% 44
2023
Q4
Sell
-100,000
Closed -$3.32M 151
2023
Q3
$3.32M Buy
+100,000
New +$3.54M 0.39% 41
2021
Q2
Sell
-26,000
Closed -$942K 72
2021
Q1
$942K Buy
+26,000
New +$923K 0.16% 48
2020
Q3
Sell
-23,188
Closed -$719K 101
2020
Q2
$719K Buy
+23,188
New +$788K 0.18% 45

Other funds holding PFE

Private Capital Management (Florida)'s PFE Position: Q1 2026 in Review

Private Capital Management (Florida) increased its Pfizer (PFE) stake by 9.1% in Q1 2026, buying an estimated $219K and bringing the position to 98,117 shares worth $2.76M. The position accounts for 0.27% of the portfolio, ranked #54.

Private Capital Management (Florida) first reported a position in PFE in Q3 2022 and has held it in 14 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Private Capital Management (Florida) held 98,117 shares of Pfizer worth $2.76M as of Q1 2026.
  • Private Capital Management (Florida) bought 8,208 Pfizer shares in Q1 2026, an estimated $219K.
  • Pfizer made up 0.27% of Private Capital Management (Florida)'s portfolio in Q1 2026, its #54 holding.
  • Private Capital Management (Florida) first reported a position in Pfizer in Q3 2022 and has held it in 14 quarters since.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Private Capital Management (Florida)'s 13F filing for Q1 2026, filed 15 May 2026.